What Are The Clinical Indications And Depth Parameters For Using Flash Lamp-Pumped Pulsed Dye Lasers (Flpdl) On Vascular Lesions? Superficial Vascular Lesions Up To 2 Mm Deep

FLPDL is primarily indicated for superficial vascular lesions no more than approximately 2 mm thick. Flash lamp-pumped pulsed dye lasers operating at 585 or 595 nm with pulse durations of roughly 300 microseconds to 2 milliseconds are most suitable for macular port-wine stains and early, superficial infantile hemangiomas. Their penetration is limited, so lesions with a deeper dermal or subcutaneous vascular component generally require a different wavelength, longer pulse strategy, or complementary techniques.

FLPDL is a superficial-vessel treatment, not a deep-lesion treatment. Use it when the target vascular network is thin, cutaneous, and up to about 2 mm deep or thick without subcutaneous extension; select longer-wavelength systems when clinically significant vessels lie deeper.

Which Vascular Lesions Are Appropriate for FLPDL?

Macular Port-Wine Stains

FLPDL is well established for macular port-wine stains, particularly when the abnormal vessels are confined to the superficial dermis. The 585–595 nm wavelength is absorbed by oxyhemoglobin, allowing thermal injury to the targeted vessels while limiting damage to surrounding skin.

Thicker, nodular, hypertrophic, or subcutaneously extending port-wine stains may respond incompletely because the laser energy does not reach the full vascular network.

Early Superficial Infantile Hemangiomas

Early-stage superficial infantile hemangiomas are another relevant indication when the lesion is thin and lacks a substantial subcutaneous component. Treatment selection should account for lesion thickness, growth stage, location, ulceration, and the risk of scarring.

Ulcerated lesions require additional caution because the damaged surface has less tolerance for thermal injury. The supplementary guidance recommends reducing fluence by approximately 15% to 20% compared with parameters used for intact superficial hemangiomas.

Telangiectasias and Small Superficial Vessels

FLPDL may also be used for selected superficial telangiectasias and small cutaneous vascular lesions. The target chromophore is oxyhemoglobin within the vessel, and the generated heat is transferred to the vessel wall, producing coagulation and eventual clearance.

The response depends on vessel diameter, depth, skin type, lesion location, and the adequacy of epidermal protection. These variables should be assessed rather than relying on wavelength alone.

What Depth Can FLPDL Treat?

The Practical Depth Limit

The key clinical boundary is a lesion thickness or vascular target depth of approximately 2 mm. FLPDL is best suited to lesions that are superficial throughout and do not extend into subcutaneous tissue.

This is a penetration constraint, not merely a preferred setting. Increasing surface fluence to force energy into a deeper lesion can raise epidermal and dermal injury without reliably treating the deeper vessels.

Why Deeper Lesions Respond Poorly

The 585–595 nm wavelengths are strongly absorbed by blood and therefore provide effective superficial vascular targeting. However, that absorption also limits how far useful energy travels into tissue.

A lesion may appear superficial at its surface while containing deeper channels beneath it. In that situation, surface clearing can occur while the deeper vascular component persists, producing incomplete treatment or recurrence.

Lesions Requiring Greater Penetration

Deep dermal or subcutaneous vascular lesions, thick hemangiomas, venous lakes, and deeper lower-extremity telangiectasias generally require a longer wavelength. Common alternatives include long-pulsed 1064-nm Nd:YAG, with selected cases also treated using 755-nm alexandrite or 800–900-nm diode systems.

For thick or deep vascular lesions, reported long-pulse approaches may use pulse durations of approximately 20–100 milliseconds, with fluence and spot size adjusted to vessel diameter, lesion depth, and skin type. These settings are not interchangeable with FLPDL parameters and carry a greater risk of thermal injury.

How Do the Parameters Relate to Clinical Use?

Wavelength

FLPDL systems commonly operate at 585 or 595 nm. Both wavelengths target hemoglobin-containing superficial vessels, while the 595-nm wavelength is often selected when somewhat greater penetration is desired within the limits of a pulsed dye laser system.

Wavelength should be chosen according to the depth and caliber of the vascular target. A small change in wavelength does not convert FLPDL into a treatment for substantially deep vascular structures.

Pulse Duration

The stated FLPDL pulse-duration range is approximately 300 microseconds to 2 milliseconds. Shorter pulses can be useful for smaller superficial vessels, while longer pulses may better accommodate larger superficial vessels by delivering heat over a longer interval.

Pulse duration should be matched to vessel size and thermal relaxation behavior. It should not be extended or intensified solely to compensate for a lesion that exceeds the device's practical penetration depth.

Clinical Endpoint

The desired immediate endpoint is transient intravascular purpura, reflecting coagulum formation within the treated vessel. This indicates that the target has received a vascular-selective thermal effect.

Epidermal whitening should be avoided. It suggests excessive epidermal heating and an increased risk of epidermal destruction, blistering, pigmentary change, or scarring.

Pulse Overlap and Pulse Stacking

Approximately 10% pulse overlap can help prevent untreated skip areas. However, direct pulse stacking or excessive overlap at vessel-rupturing fluences should be avoided.

Vessel rupture can release hemoglobin into the surrounding tissue, increasing nonspecific thermal and inflammatory injury. The objective is controlled vascular coagulation rather than unnecessary mechanical disruption.

When Should Another Laser Be Chosen?

Deep Venous Lakes

Venous lakes and other deeper red-blue vascular lesions often extend into deeper dermal layers. PDL is effective for superficial components, but deeper channels generally respond better to longer-wavelength, high-powered systems.

For example, reported approaches include a 755-nm alexandrite laser using a 6-mm spot, approximately 3-ms pulses, and 60–80 J/cm², or a 1064-nm Nd:YAG laser using a 3–5-mm spot and 50–100 J/cm². These are device- and patient-dependent parameters requiring appropriate cooling and clinical expertise.

Lower-Extremity Telangiectasias and Leg Veins

Long-pulsed Nd:YAG systems are commonly preferred when vessels are deeper or larger, particularly in the lower extremities. The longer wavelength penetrates more deeply and can treat vessels that are beyond the effective reach of 585–595 nm FLPDL.

Longer pulse durations help conduct heat across larger vessel walls and may reduce the likelihood of vessel rupture. Epidermal cooling remains important because the higher energy required for deep treatment can cause burns, crusting, scarring, or post-inflammatory hyperpigmentation.

Lesions With a Subcutaneous Component

A visible or palpable subcutaneous component is a strong reason to reconsider FLPDL as the sole treatment. Treating only the superficial portion may produce a temporary surface response while leaving the deeper vascular network untreated.

Treatment planning should therefore include clinical assessment of thickness and, when appropriate, imaging or other evaluation of the lesion's depth.

Understanding the Trade-offs

Increasing Energy Does Not Solve Limited Penetration

Higher fluence may increase superficial heating without providing safe, effective treatment of deeper vessels. The likely result is a greater risk of epidermal and nonspecific dermal injury rather than reliable clearance of the deep component.

The correct response to inadequate depth is usually a better-matched wavelength or treatment strategy, not indiscriminate escalation of FLPDL energy.

Cooling Protects the Surface but Does Not Replace Depth

Surface cooling can protect the epidermis and improve the safety margin during vascular laser treatment. Compression may also modify the vascular target in selected settings.

Neither technique changes the fundamental limitation that FLPDL is best suited to superficial lesions. Cooling supports safe treatment; it does not make a 2-mm-capable approach equivalent to a deep-penetrating laser.

Treatment Often Requires Multiple Sessions

Vascular clearance commonly requires a series of treatments rather than one exposure. The supplementary guidance describes approximately three to four treatments at three- to four-week intervals for many vascular indications, although the schedule must be adapted to lesion type, healing, response, and device parameters.

Ulcerated lesions may be treated at shorter intervals, such as approximately two weeks, when clinically appropriate and when re-epithelialization and tissue recovery are carefully monitored.

Deeper Treatments Carry Greater Thermal Risk

Longer-wavelength systems can reach deeper vessels but may require higher fluence and longer pulses. This increases the importance of accurate vessel assessment, conservative parameter selection, and effective epidermal cooling.

The deeper the target, the more important it becomes to balance vessel coagulation against the risk of collateral dermal and epidermal injury.

Making the Right Choice for Your Goal

The treatment decision should begin with the lesion's true vascular depth, not simply its color or surface appearance.

If your primary focus is a macular port-wine stain: FLPDL at 585–595 nm is appropriate when the lesion is superficial and no more than approximately 2 mm thick without subcutaneous extension.
If your primary focus is an early superficial infantile hemangioma: FLPDL can be considered when the lesion is thin and superficial, with reduced fluence and added caution if ulceration is present.
If your primary focus is a deep, thick, or subcutaneous vascular lesion: Choose a longer-wavelength system, such as long-pulsed 1064-nm Nd:YAG, rather than increasing FLPDL energy beyond a safe superficial treatment range.
If your primary focus is minimizing surface injury: Use the lowest effective parameters, appropriate cooling, controlled pulse overlap, and transient purpura as the endpoint while avoiding epidermal whitening.

The safest and most effective vascular laser treatment is the one whose wavelength and pulse parameters match the depth and size of the target vessel.

Summary Table:

Indication	Depth Limit	Wavelength	Pulse Duration	Endpoint
Macular port-wine stains	≤2 mm	585/595 nm	0.3-2 ms	Transient purpura
Early superficial hemangiomas	≤2 mm	585/595 nm	0.3-2 ms	Transient purpura
Telangiectasias	≤2 mm	585/595 nm	0.3-2 ms	Transient purpura

Looking for the right laser system for your clinic? BELIS offers professional-grade aesthetic equipment, including advanced FLPDL systems for vascular lesion treatment. Our devices are designed for superficial vascular lesions up to 2 mm deep, ensuring safe and effective results. Contact us today to find the perfect solution for your practice and elevate your patient care. Get in touch now!